Low molecular weight heparin vs unfractionated heparin
All‐cause mortality · patients with cancer with venous thromboembolism
Low molecular weight heparin showed no clear difference in mortality compared with unfractionated heparin (low certainty).
1 finding from 1 review
- Anticoagulation for the initial treatment of venous thromboembolism in people with cancer 2021 · Cochrane Headline outcomes onlyRR 0.66 [0.4, 1.1]5 studies · 418 participantsLow